PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • The Company is currently leveraging its GPCR expertise and proprietary StaR?? technology to build a pipeline of best-in-class and first-in-class GPCR-targeted medicines for the treatment of CNS, metabolic and other diseases.
http://www.w3.org/ns/prov#wasQuotedFrom
  • biospace.com